Blood, Plasma, Serum
|
Reference Range
|
|
| |
|
Alanine aminotransferase (ALT), serum
|
8-40 U/L
|
|
| |
|
Alkaline phosphatase, serum
|
|
Male
|
30-100 U/L
|
|
|
Female
|
45-115 U/L
|
|
| |
|
Amylase, serum
|
25-125 U/L
|
|
| |
|
Aspartate aminotransferase (AST), serum
|
8-40 U/L
|
|
| |
|
Bilirubin, serum (adult)
|
|
Total
|
0.1-1.0 mg/dL
|
|
|
Direct
|
0.0-0.3 mg/dL
|
|
| |
|
Calcium, serum (total)
|
8.4-10.2 mg/dL
|
|
| |
|
Cholesterol, serum
|
|
Total
|
150-240 mg/dL
|
|
|
HDL
|
30-70 mg/dL
|
|
|
LDL
|
<160 mg/dL
|
|
| |
|
Cortisol, serum
|
|
0800 h
|
5-23 μg/dL
|
|
|
1600 h
|
3-15 μg/dL
|
|
|
2000 h
|
50% of 0800 h
|
|
| |
|
Creatine kinase, serum
|
|
Male
|
25-90 U/L
|
|
|
Female
|
10-70 U/L
|
|
| |
|
Creatinine, serum
|
0.6-1.2 mg/dL
|
|
| |
|
Electrolytes, serum
|
|
Sodium (Na+)
|
136-145 mEq/L
|
|
|
Potassium (K+)
|
3.5-5.0 mEq/L
|
|
|
Chloride (Cl–)
|
95-105 mEq/L
|
|
|
Bicarbonate (HCO3–)
|
22-28 mEq/L
|
|
|
Magnesium (Mg2+)
|
1.5-2.0 mEq/L
|
|
| |
|
Estriol, total, serum (in pregnancy)
|
|
24-28 wks
|
30-170 ng/mL
|
|
|
28-32 wks
|
40-220 ng/mL
|
|
|
32-36 wks
|
60-280 ng/mL
|
|
|
36-40 wks
|
80-350 ng/mL
|
|
| |
|
Ferritin, serum
|
|
Male
|
15-200 ng/mL
|
|
|
Female
|
12-150 ng/mL
|
|
| |
|
Follicle-stimulating hormone, serum/plasma
|
|
Male
|
4-25 mIU/mL
|
|
|
Female
|
|
|
|
premenopause
|
4-30 mIU/mL
|
|
|
midcycle peak
|
10-90 mIU/mL
|
|
|
postmenopause
|
40-250 mIU/mL
|
|
| |
|
Gases, arterial blood (room air)
|
|
pH
|
7.35-7.45
|
|
|
Pco2
|
33-45 mm Hg
|
|
|
Po2
|
75-105 mm Hg
|
|
| |
|
Glucose, serum
|
|
Fasting
|
70-110 mg/dL
|
|
|
2-h postprandial
|
<120 mg/dL
|
|
| |
|
Growth hormone- arginine stimulation
|
|
Fasting
|
<5 ng/mL
|
|
|
Provocative stimuli
|
>7 ng/mL
|
|
| |
|
Immunoglobulins, serum
|
|
IgA
|
76-390 mg/dL
|
|
|
IgE
|
0-380 IU/mL
|
|
|
IgG
|
650-1,500 mg/dL
|
|
|
IgM
|
40-345 mg/dL
|
|
| |
|
Iron
|
50-170 μg/dL
|
|
| |
|
Lactate dehydrogenase, serum
|
45-90 U/L (100-250 IU/L)
|
|
| |
|
Luteinizing hormone, serum/plasma
|
|
Male
|
6-23 mIU/mL
|
|
|
Female
|
|
follicular phase
|
5-30 mIU/mL
|
|
|
midcycle
|
75-150 mIU/mL
|
|
|
postmenopause
|
30-200 mIU/mL
|
|
| |
|
Osmolality, serum
|
275-295 mOsmol/kg H2O
|
|
| |
|
Parathyroid hormone, serum, N-terminal
|
10-65 pg/mL
|
|
| |
|
Phosphate (alkaline), serum (p-NPP at 30° C)
|
20-70 U/L
|
|
| |
|
Phosphorus (inorganic), serum
|
3.0-4.5 mg/dL
|
|
| |
|
Prolactin, serum (hPRL)
|
<20 ng/mL
|
|
| |
|
Proteins, serum
|
|
Total (recumbent)
|
6.0-7.8 g/dL
|
|
|
Albumin
|
3.5-5.5 g/dL
|
|
|
Globulin
|
2.3-3.5 g/dL
|
|
| |
|
Thyroid-stimulating hormone (TSH), serum
|
0.5-5.0 μU/mL
|
|
| |
|
Thyroidal iodine (123I) uptake
|
8%-30% of administered dose/24 h
|
|
| |
|
Thyroxine (T4), serum
|
5-12 μg/dL
|
|
| |
|
Triglycerides, serum
|
35-160 mg/dL
|
|
| |
|
Triiodothyronine (T3), serum (RIA)
|
115-190 ng/dL
|
|
| |
|
Triiodothyronine (T3) resin uptake
|
25%-35%
|
|
| |
|
Urea nitrogen, serum (BUN)
|
7-18 mg/dL
|
|
| |
|
Uric acid, serum
|
3.0-8.2 mg/dL
|
|
| |
|
|
Hematologic
|
Reference Range
|
|
| |
|
Bleeding time (template)
|
2-7 minutes
|
|
| |
|
CD4+ T-lymphocyte count
|
>500 mm3
|
|
| |
|
Erythrocyte count
|
|
Male
|
4.3-5.9 million/mm3
|
|
|
Female
|
3.5-5.5 million/mm3
|
|
| |
|
Erythrocyte sedimentation rate (Westergren)
|
|
Male
|
0-15 mm/h
|
|
|
Female
|
0-20 mm/h
|
|
| |
|
Hematocrit
|
|
Male
|
41%-53%
|
|
|
Female
|
36%-46%
|
|
| |
|
Hemoglobin A1c
|
≤6%
|
|
| |
|
Hemoglobin, blood
|
|
Male
|
13.5-17.5 g/dL
|
|
|
Female
|
12.0-16.0 g/dL
|
|
| |
|
Leukocyte count and differential
|
|
Leukocyte count
|
4,500-11,000/mm3
|
|
|
Neutrophils, segmented
|
54%-62%
|
|
|
Neutrophils, banded
|
3%-5%
|
|
|
Eosinophils
|
1%-3%
|
|
|
Basophils
|
0%-0.75%
|
|
|
Lymphocytes
|
25%-33%
|
|
|
Monocytes
|
3%-7%
|
|
| |
|
Mean corpuscular hemoglobin (MCH)
|
25.4-34.6 pg/cell
|
|
| |
|
Mean corpuscular hemoglobin concentration (MCHC)
|
31%-36% Hb/cell
|
|
| |
|
Mean corpuscular volume (MCV)
|
80-100 μm3
|
|
| |
|
Partial thromboplastin time (activated)
|
25-40 seconds
|
|
| |
|
Platelet count
|
150,000-400,000/mm3
|
|
| |
|
Prothrombin time
|
11-15 seconds
|
|
| |
|
Reticulocyte count
|
0.5%-1.5% of red cells
|
|
| |
|
Thrombin time
|
<2 seconds deviation from control
|
|
| |
|
Volume
|
|
Plasma
|
|
Male
|
25-43 mL/kg
|
|
|
Female
|
28-45 mL/kg
|
|
|
Red cell
|
|
Male
|
20-36 mL/kg
|
|
|
Female
|
19-31 mL/kg
|
|
Cerebrospinal Fluid
|
Reference Range
|
|
| |
|
Cell count
|
0-5/mm3
|
|
| |
|
Chloride
|
118-132 mEq/L
|
|
| |
|
Gamma globulin
|
3%-12% of total proteins
|
|
| |
|
Glucose
|
40-70 mg/dL
|
|
| |
|
Pressure
|
70-180 mm H2O
|
|
| |
|
Proteins, total
|
<40 mg/dL
|
|
| |
|
|
Sweat
|
Reference Range
|
|
| |
|
Chloride
|
0-35 mmol/L
|
|
| |
|
Urine
|
Reference Range
|
|
| |
|
Calcium
|
100-300 mg/24 h
|
|
| |
|
Chloride
|
Varies with intake
|
|
| |
|
Creatine clearance
|
|
Male
|
97-137 mL/min
|
|
|
Female
|
88-128 mL/min
|
|
| |
|
Estriol, total (in pregnancy)
|
|
30 wks
|
6-18 mg/24 h
|
|
|
35 wks
|
9-28 mg/24 h
|
|
|
40 wks
|
13-42 mg/24 h
|
|
| |
|
17-hydroxycorticosteroids
|
|
Male
|
3.0-10.0 mg/24 h
|
|
|
Female
|
2.0-8.0 mg/24 h
|
|
| |
|
17-ketosteroids, total
|
|
Male
|
8-20 mg/24 h
|
|
|
Female
|
6-15 mg/24 h
|
|
| |
|
Osmolality
|
50-1,400 mOsmol/kg H2O
|
|
| |
|
Oxalate
|
8-40 μg/mL
|
|
| |
|
Proteins, total
|
<150 mg/24 h
|
|
| |
|
Sodium, total
|
varies with diet
|
|
| |
|
Uric acid
|
varies with diet
|
|
| |
Body Mass Index (Adult)
|
19-25 kg/m2
|
|
| |
|
|
|
|
|
|